4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-23-036078
Director sold 8,520 shares at an average $17.44 ($148,591)
- Director acquired 8,289 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ho Maykin · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-07 | Grant or award : show line 1 in the form 10b5-1 | +8,289 | 40,021 | D | ||
| 2023-06-08 | Sale : show line 2 in the form 10b5-1 | −2,295 | $16.79 | $38,533 | 37,726 | D |
| 2023-06-08 | Sale : show line 3 in the form 10b5-1 | −6,225 | $17.68 | $110,058 | 31,501 | D |
| Open-market sales · 8,520 sh · avg $17.44 · $148,591 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-07 | Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | +12,666 | 12,666 | D |
Loading xslF345X04/doc4.xml…